Among them, TIM3 (encoded by HAVCR2) is an interesting candidate and has gained much attraction because it is expressed in both CD34+CD38− LSCs and CD34+CD38+ LPCs in the vast majority of AML subtypes but not in normal HSC counterpart [11, 12]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.